C21 Investments Inc. (CSE: CXXI)
Canada
· Delayed Price · Currency is CAD
0.275
-0.010 (-3.51%)
Dec 20, 2024, 4:00 PM EST
C21 Investments Revenue
In the fiscal year ending March 31, 2024, C21 Investments had annual revenue of $26.79M USD, down -5.29%. C21 Investments had revenue of $7.51M in the quarter ending September 30, 2024, with 4.84% growth.
Revenue
$26.79M
Revenue Growth
-7.96%
P/S Ratio
n/a
Revenue / Employee
$235.00K
Employees
114
Market Cap
33.01M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 26.79M | -1.50M | -5.29% |
Jan 31, 2024 | 28.29M | -603.21K | -2.09% |
Jan 31, 2023 | 28.89M | -4.09M | -12.41% |
Jan 31, 2022 | 32.98M | -483.09K | -1.44% |
Jan 31, 2021 | 33.47M | -4.24M | -11.24% |
Jan 31, 2020 | Pro | Pro | Pro |
Jan 31, 2019 | Pro | Pro | Pro |
Jan 31, 2018 | Pro | Pro | Pro |
Jan 31, 2017 | Pro | Pro | Pro |
Jan 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries Inc. | 1.51B |
Trulieve Cannabis Corp. | 1.58B |
Cresco Labs Inc. | 981.27M |
Grown Rogue International Inc. | 28.83M |
Planet 13 Holdings Inc. | 147.38M |
Jushi Holdings Inc. | 350.48M |
Ayr Wellness Inc. | 627.53M |
MariMed Inc. | 213.26M |